NCT07313488

Brief Summary

To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the Post-Anesthesia Care Unit (PACU) reduces the incidence of desaturations

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 2, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

9 months

First QC Date

December 17, 2025

Last Update Submit

December 17, 2025

Conditions

Surgery

Keywords

SurgeryOxygen saturation monitoring

Outcome Measures

Primary Outcomes (1)

  • Reduction of the incidence of desaturations

    To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the PACU reduces the incidence of desaturations by recording: * The last SpO₂ reading taken upon leaving the operating room * The first SpO₂ reading taken upon arrival in the recovery room * The lowest SpO₂ reading taken during the transfer between the operating room and the recovery room (for patients monitored by pulse oximetry)

    upon Arrival in the Recovery Room

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient (≥ 18 years old) scheduled for surgery under general anesthesia at the HUS between January 1, 2024 and April 30, 2025

You may qualify if:

  • Adult patient (≥ 18 years old)
  • Patient scheduled for surgery under general anesthesia at the HUS between January 1, 2024 and April 30, 2025

You may not qualify if:

  • \- Administration of premedication that may impair judgment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service d'Anesthésie - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

Central Study Contacts

Vincent MATEO, MD

CONTACT

33 3 69 55 00 87vincent.mateo@chru-strasbourg.fr

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2025

First Posted

January 2, 2026

Study Start

May 20, 2025

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

January 2, 2026

Record last verified: 2025-12

Locations

FR(1)